# Vizgen

Vizgen launched MERFISH 2.0 chemistry and enhanced OmniVue panels with antibody-drug-conjugate (ADC) biomarker capability in 2026, alongside a spatial multi-omics roadmap unveiled at AGBT 2026 and new volumetric tissue-mapping capability presented at the Human Cell Atlas 2026 meeting.

Source: https://en.bioecon.ru/companies/vizgen/
Updated: 2026-07-06

- Country: United States

## Technologies

- [Spatial epigenomics](https://en.bioecon.ru/technology/spatial-epigenomics/)
- [Spatial transcriptomics & spatial multi-omics](https://en.bioecon.ru/technology/spatial-transcriptomics-spatial-multi-omics/)